• Utility Values in Economic Models for Treatments of Schizophrenia

    Nov 1, 2016, 00:00

  • The Economic Impact of Using Antimicrobial Catheters Impregnated with Rifampin and Clindamycin to Reduce Infection Rates in External Ventricular Drainage- A Budget Impact Analysis

    Nov 1, 2016, 00:00

  • Do First-In-Class Drugs Offer Larger Incremental Health Gains Than Next-In-Class Drugs?

    Nov 1, 2016, 00:00

  • Antimicrobial Susceptibility Pattern in Chronic Suppurative Otitis Media Patient in a Tertiary Care Hospital

    Nov 1, 2016, 00:00

  • Performance of Search Filters to Identify Health State Utility Studies

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Nivolumab in Combination with Ipilimumab in First-Line Treatment of Advanced Melanoma in Sweden

    Nov 1, 2016, 00:00

  • Analyzing The Revenues And Expenditures Of The Hungarian Health Insurance Fund Between 1993-2015

    Nov 1, 2016, 00:00

  • Economic Evaluation of Pertuzumab Neoadjuvant Treatment for Patients with Locally Advanced, Inflammatory, or Early Stage HER2-Positive Breast Cancer in Greece

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Interferon-Gamma Release Assay for Tuberculosis Screening of Mental Patients with Tobacco Smoking

    Nov 1, 2016, 00:00

  • Recommendations on Cognitive Debrief and Usability Studies for Instrument Migration from Paper to Electronic Modalities Based on A Qualitative Synthesis of Validation Studies

    Nov 1, 2016, 00:00

  • Effectiveness of Trigger Tools to Detect Adverse Drug Events from Discharge Summaries- A Retrospective Study

    Nov 1, 2016, 00:00

  • Identification of Statin Intoleran Results From A Survey of South Korean Clinicians

    Nov 1, 2016, 00:00

  • Evaluation of Potential Drug-Drug Interactions among the People Living with HIV with Highly Active Antiretroviral Therapy at Kasturba Hospital

    Nov 1, 2016, 00:00

  • Quasi-Experimental Methods For Real World Data

    Nov 1, 2016, 00:00

  • Retrospective Database Analysis on Anaphylaxis And Patient Concordance In The United States

    Nov 1, 2016, 00:00

  • Rationing Resources in Health By Involving the Public in Priority Setting

    Nov 1, 2016, 00:00

  • The Factors Related with Patient Experience of Medication- A Multilevel Analysis

    Nov 1, 2016, 00:00

  • Systematic Review of Quality of Life Measurement Instruments and Response Criteria Among Patients with Myelodysplastic Syndromes

    Nov 1, 2016, 00:00

  • Health Technology Assessment Supports Evidence-Based Decision-Making in The Changi General Hospital Marketplace Exercise

    Nov 1, 2016, 00:00

  • Effectiveness of Pharmacists-Led Provider-Focused Interventions to Improve Hpv Vaccination Rates in Adults in Malaysia

    Nov 1, 2016, 00:00

  • Words (Excluding Tãtle and Authors- 300) Title- Cost-Effectiveness Analysis of Nivolumab for the Treatment of Second-Line Advanced Squamous Non-Small Cell Lung Cancer (Nsclc) in Spain

    Nov 1, 2016, 00:00

  • What Impact is the Evolving Health Care Landscape Having on Access to Innovative Medicines in China?

    Nov 1, 2016, 00:00

  • HTA Agencies Perspective on Progression-Free-Survival (PFS)

    Nov 1, 2016, 00:00

  • The Evaluation of Innovative Drugs Applying Business Valuation Concepts

    Nov 1, 2016, 00:00

  • Epidemiology and Survival in Prostate Cancer; A Population Based Study Analysing The Hungarian National Health Insurance Found Database

    Nov 1, 2016, 00:00

  • Prevalence of Obesity And Overweight And Associated Factors Among Financial Institution Workers In Accra Metropolis, Ghana- A Case Control Study

    Nov 1, 2016, 00:00

  • Monitoring Treatment Response in Metastasic Colorectal Cancer- Economic Evaluation Of CTC-Test Versus CT Scan

    Nov 1, 2016, 00:00

  • Micro-Costing Analysis of Procedures on Varicose Veins Performed in Outpatient Setting

    Nov 1, 2016, 00:00

  • Attitude And Willingness To Participate on Screening of First-Degree Relatives of Colorectal Cancer Patients

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Intravitreal Aflibercept (IVT-AFL) in Treatment of Macular Edema (ME) Secondary to Branch Retinal Vein Occlusion (BRVO)

    Nov 1, 2016, 00:00

  • Cost Analysis of Therapy with Idursulfase For Hunter Syndrome In Bulgaria

    Nov 1, 2016, 00:00

  • Monitoring Evidence-Based Technology Incorporation- The Case of Biological Rheumatoid Arthritis Drugs In Brazil From 2010 to 2014

    Nov 1, 2016, 00:00

  • Cost-minimization Analysis of Pegaspargase And Native E. Coli Asparaginase To Treat Children And Adults with Acute Lymphoblastic Leukemia In Belgium

    Nov 1, 2016, 00:00

  • Using Simulated Individual Patient Data (IPD) From Published Registry and Ipd From The Seer-Medicare Registry To Extrapolate Results From Randomised Clinical Trials (RCTS) in Metastatic Melanoma

    Nov 1, 2016, 00:00

  • The Value of Mcda in Health Technology Assessment- A Explorative Study in the Dutch Context

    Nov 1, 2016, 00:00

  • A Cost-Minimization Analysis of Dermatophyte Test Kit with Onychomycosis Under Health Care System in Japan

    Nov 1, 2016, 00:00

  • Budget Impact Analysis of First-Line Treatment with Branded Pemetrexed (ALIMTA) for Advanced Non-Squamous Non-Small Cell Lung Cancer in China

    Nov 1, 2016, 00:00

  • Historical and Future Oral Lipid Modifying Therapy Market Size in Top Five European Countries

    Nov 1, 2016, 00:00

  • Utilization of Topical Tacrolimus and Topical Pimecrolimus in Europe- Results From The Joint European Longitudinal Lymphoma and Skin Cancer Evaluation (Joelle) Study

    Nov 1, 2016, 00:00

  • Tamoxifen for the Primary Prevention of Breast Cancer- New Life for an Old Drug

    Nov 1, 2016, 00:00

  • Social and Economic Burden of Skin Disease in Europe. A Narrative review of the Literature

    Nov 1, 2016, 00:00

  • Development Of A Search Engine For The Medline Database With Search Results Ranking From The Perspective Of Evidence-Based Medicine

    Nov 1, 2016, 00:00

  • Cost-Utility Analysis of Herpes Zoster Vaccine in Thailand

    Nov 1, 2016, 00:00

  • Analysis of the Indicator "Threshold Willingness To Pay" in Leukemia Patients by Gender According to the Survey in Ukraine

    Nov 1, 2016, 00:00

  • Impact of Patient Race and Geography on Access and use of Adjuvant Endocrine Therapy in Medicare Breast Cancer Survivors

    Nov 1, 2016, 00:00

  • Economic Impact of Drug Addiction Interventions in Adult Population- The Peru Case

    Nov 1, 2016, 00:00

  • Evaluation of Glycemic Control with the Combination of Biphasic Insulin and Metformin Therapy in Type 2 Diabetes Mellitus Patients

    Nov 1, 2016, 00:00

  • Prevalence and Environmental Risk Factors of Self-Reported Acne in Mexico

    Nov 1, 2016, 00:00

  • Evaluating The Economic Burden and Health Care Utilization of Lung Cancer in The Us Medicare Population

    Nov 1, 2016, 00:00

  • Market Exclusivity Periods And Patent Challenges In Pharmaceuticals In South Korea

    Nov 1, 2016, 00:00

  • Overall Survival Versus Progression-Free Survival in Oncology Clinical Trials

    Nov 1, 2016, 00:00

  • Factors Influencing Door-To-Doctor Time In An Emergency Department- Discrete Event Simulation Model

    Nov 1, 2016, 00:00

  • Use of Net Monetary Benefit Analysis to Comprehensively Understand the Value of Innovative Treatments

    Nov 1, 2016, 00:00

  • Cancer Drugs in Europe- A Comparison of HTA Processes and Decisions for New and Innovative Oncology Therapies in France, Germany and The UK – An Analysis Using The Prismaccess Database

    Nov 1, 2016, 00:00

  • Comorbidity-Based Eq-5d Scores Of Primary Care Patients In Finland, Their Potential To Benefit And Unmet Medical Need

    Nov 1, 2016, 00:00

  • Data Mining Used To Characterize Discordance In Gastric Cancers HER2 Status Determination To Help For A Better Treatment Decision

    Nov 1, 2016, 00:00

  • Impact of Comorbidities on Medication Adherence In Hypertensive Patients

    Nov 1, 2016, 00:00

  • Valuing Informal Care- Making Normative Judgments in A Positive Milieu

    Nov 1, 2016, 00:00

  • The Impact of Community Pharmacies (CP) On Regional Equity In The Access To The Portuguese Needle And Exchange Programme (NEP)

    Nov 1, 2016, 00:00

  • Developing A Conceptual Framework and a Tool for Measuring Absorptive Capacity in Pharmaceutical Companies

    Nov 1, 2016, 00:00

  • The Role of Pharmacy Information Systems, Formulary Arrangmnet,Supplay Chain And Distrbution System To Improve Patients' Access To Prescription Drug In Saudi Hospitals- A Cross-Sectional Descriptive Study

    Nov 1, 2016, 00:00

  • Health State Utilities in Chronic Heart Failure in The UK- A Systematic Review

    Nov 1, 2016, 00:00

  • Budget Impact Analysis for Intracameral Injectable Solution Combining Two Mydriatics and One Anaesthetic for Cataract Surgery

    Nov 1, 2016, 00:00

  • Eficacy And Satefy of Methylprednisolone In The Treatment of Idiopathic Thrombocytopenic Purpura

    Nov 1, 2016, 00:00

  • Treatment Cost of Post Myocardial Infarction- An Analysis in Heart Institute in Ho Chi Minh City, Vietnam

    Nov 1, 2016, 00:00

  • Evaluating the Cost-Effectiveness of Liraglutide 1.8Mg Versus Lixisenatide 20μg for the Treatment of Type 2 Diabetes Mellitus in the Spanish Setting

    Nov 1, 2016, 00:00

  • Clinical And Econimic Burden Of Community-Onset Complicated Skin And Skin Structure Infection (Csssi) In Korea

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Bariatric Surgery For The Treatment of Morbid Obesity Patients Compared With Conservative Management In Spain

    Nov 1, 2016, 00:00

  • High Risk of Depression In Patients with Heart Failure in Germany

    Nov 1, 2016, 00:00

  • Identification of Statin Intoleran Results From A Survey of Clinicians in Taiwan

    Nov 1, 2016, 00:00

  • The Nice Accelerated Access Review, How Does it Compare to The Dutch Conditional Reimbursement Pathway?

    Nov 1, 2016, 00:00

  • comparative Evaluation of Safety, Efficacy and Cognitive Profile of Amisulpride and Olanzapine in Schizophrenia Patients- A Prospective Study

    Nov 1, 2016, 00:00

  • The Cost-Effectiveness Of Delayed-Release Dimethyl Fumarate Versus Glatiramer Acetate For The Treatment Of Relapsing-Remitting Multiple Sclerosis In The Chilean National Health Fund (Fonasa)

    Nov 1, 2016, 00:00

  • Psychometric Analyses of Clinical Outcome Assessment (Coa) Questionnaires Designed to Evaluate Satisfaction with Pharmacological Stress Agents (Psas) Used in Echocardiography

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Analysis of Screening Strategies for Atrial Fibrillation in England and Wales

    Nov 1, 2016, 00:00

  • Healthcare Pathway and Costs Analysis in Patients with Metastatic Prostate Cancer (MPC)

    Nov 1, 2016, 00:00

  • Systematic Review of Psychometric Properties of The EQ-5D Questionnaires In Patients with Hematologic Malignant Neoplasms

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Analysis of Non-Invasive Prenatal Testing for Down's Syndrome in China

    Nov 1, 2016, 00:00

  • A Cost Comparison of 1l Treatment Regimens for Metastatic Colorectal Cancer (MCRC) in Italy

    Nov 1, 2016, 00:00

  • Biologics use in Crohn’s Disease in France

    Nov 1, 2016, 00:00

  • Healthcare Cost of Patients Presenting with Peripheral Artery Disease (PAD)- An Analysis Using A Claims Database in France

    Nov 1, 2016, 00:00

  • Market Access Pathways for Drugs with EMA Conditional Approval

    Nov 1, 2016, 00:00

  • Building Intentions with the Theory of Planned Behaviour- The Mediating Role of Knowledge and Expectations in Successful New Pharmacy Public Health Services Implementation

    Nov 1, 2016, 00:00

  • Lifestyle Beliefs Of 672 Patients With Rheumatoid Arthritis Or Axial Spondyloarthritis

    Nov 1, 2016, 00:00

  • Economic Evaluation Of Abbvie’s Regimen (Viekirax) For Patients With Genotype 4 Hcv In Greece

    Nov 1, 2016, 00:00

  • Direct Cost Estimation of Psoriatic Arthritis Treatment In Turkey- Results From A Delphi Panel

    Nov 1, 2016, 00:00

  • Risk Factors Influencing Cardiovascular Disease in Indian Women with Type 2 Diabetes Mellitus- A Retrospective Case-Control Study

    Nov 1, 2016, 00:00

  • Evaluation Of Clinical And Economic Impact Of Drug Related Problems In Elderly Patients At Tertiary Care Hospital

    Nov 1, 2016, 00:00

  • Patient Centricity – Patient Related Programs In The German Healthcare Environment

    Nov 1, 2016, 00:00

  • Caregiver Burden and Quality of Life of Informal Caregivers of Stroke Patients- A Prospective Study

    Nov 1, 2016, 00:00

  • High Demand For Post-Exposure Prophylaxis (PEP) For Consensual Sex Exposure Suggests A Need For Pre-Exposure Prophylaxis (PREP) In Uganda

    Nov 1, 2016, 00:00

  • Prescribing Patterns of Psychostimulants, Agents Used For ADHD And Nootropics

    Nov 1, 2016, 00:00

  • Conceptual Modelling for Cost-Effectiveness Analysis of Intravitreal Therapy with Ranibizumab, Aflibercept or Bevacizumab for Macular Oedema Due to Central Retinal Vein Occlusion

    Nov 1, 2016, 00:00

  • Patient Counseling By A Specialty Pharmacist Increases Pain Medication Adherence And Persistency

    Nov 1, 2016, 00:00

  • My Opinions Matter! How Perspectives, Knowledge And Expectations Matter in Moderating the Success of New Pharmaceutical Services Implementation in Malaysia

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Prophylaxis Compared to On-Demand Treatment in Severe Haemophilia a. Systematic Review

    Nov 1, 2016, 00:00

  • Health-Economic Evaluation of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir for Treatment of Chronic Genotype 1 Hcv Infection in Germany

    Nov 1, 2016, 00:00

  • Schools' Perspective on Promoting Rational use of Antibiotics in New Delhi, India – A Qualitative Study

    Nov 1, 2016, 00:00

  • Access To Orphan Drugs In Poland - Is Change In Health Technology Assessment Approach Required?

    Nov 1, 2016, 00:00

  • Cochlear Implant In Prelingually Deafened Oralist Adults- Speech Perception Outcome, Subjective Benefits And Quality Of Life Improvement

    Nov 1, 2016, 00:00

  • Challenging Model Complexity; A Simpler Approach For Developing Markets

    Nov 1, 2016, 00:00

  • Real-World Outcomes of Novel Treatments in Patients with Advanced Melanoma in The Netherlands

    Nov 1, 2016, 00:00

  • Spinal Cord Stimulation Versus Conventional Medical Management for Failed Back Surgery Syndrome- A Dutch Cost-Effectiveness Analysis

    Nov 1, 2016, 00:00

  • Exploring Pharmacist's Role In Palliative Care- A Qualitative Study

    Nov 1, 2016, 00:00

  • Cost-of-Illness of Acromegaly in Sweden – A Register-Linkage Population-Based Study

    Nov 1, 2016, 00:00

  • Physical Activity and Health-Related Quality of Life Among Adults with Type 2 Diabetes- Results from Wearable Fitness Trackers

    Nov 1, 2016, 00:00

  • Improving Patients Quality of Life By Valuation of Patient Satisfaction With Specific Characteristics of Rehabilitation Medical Devices - Weight, Fit, Appearance, Comfort, Pain Free, Free of Abrasiveness, Ease of Application And Durability

    Nov 1, 2016, 00:00

  • English CCG Formularies- Resources And Priorities

    Nov 1, 2016, 00:00

  • An Anchor-Based Approach to Define an Impaired Day in Migraine Patients Utilizing the Migraine Physical Function Impact Diary

    Nov 1, 2016, 00:00

  • Orphan Drug Shortage in The United States- A Long Lasting Public Health Issue Calling for Effective Policies

    Nov 1, 2016, 00:00

  • Demographic and Clinical Characteristics of Migraine Patients in Denmark

    Nov 1, 2016, 00:00

  • Compiling and Reconciling Evidence to Assign Risk of Febrile Neutropenia to Chemotherapy Regimens

    Nov 1, 2016, 00:00

  • Cumulative Cost of Treatment with ILUVIEN (Fluocinolone Acetonide [FAC]) Versus the Current Standard of Care in the Treatment of Visual Impairment Due to Diabetic Macular Oedema (DMO) in Phakic Eyes Over a 3 Year Period- An Analysis from a ...

    Nov 1, 2016, 00:00

  • Cost-Utility Analysis of Atazanavir/Ritonavir 200/100 Mg Versus Atazanavir/Ritonavir 300/100 Mg in Thai Adults with Virologic Suppression

    Nov 1, 2016, 00:00

  • Impact of Glucosamin and Chondroitin Sulfates Combination (GCSC) on the Burden of Osteorthritis over 6 Months in Portugal- An Observational Study

    Nov 1, 2016, 00:00

  • Susceptibility Pattern of Pseudomonas Aeruginosa Isolates to Carbapenem Antibiotics

    Nov 1, 2016, 00:00

  • Assessment Of Patient Need During Hospitalization By Using Neq (Need Evaluation Questionnaire) In Tertiary Care Hospitals, Quetta, Pakistan

    Nov 1, 2016, 00:00

  • Assesing The Average Price Level Of Generics In Greece And Other Comparable European Countries Relative To Their Volume Market Share

    Nov 1, 2016, 00:00

  • Reconstruction Of Major Lower-Extremity Amputation Stump With A Free Latissimus Dorsi Flap

    Nov 1, 2016, 00:00

  • Assess the Medication Adherence in Patients with Severe Mental Illness Attending Public Tertiary Care Hospitals of Quetta, Pakistan

    Nov 1, 2016, 00:00

  • The Burden of Parkinson's Disease(Pd) in Japan

    Nov 1, 2016, 00:00

  • Inpatient Costs of Agitation and Containment in an Urban Area

    Nov 1, 2016, 00:00

  • Reweighting Rct Evidence To Better Reflect Real Life- A Case Study of The Innovation Medicines Initiative

    Nov 1, 2016, 00:00

  • Development of Hospital Formulary in Japan - Current Trends and Issues

    Nov 1, 2016, 00:00

  • Health Utility Measured with EQ-5D-5L in Japanese Patients Undergoing Hemodialysis

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Evaluation of Vortioxetine in Major Depressive Episode in the UK Setting

    Nov 1, 2016, 00:00

  • Physicians’ Behavior Influences the Health and Economic Impact of Applying Circulating Tumor Cells as Response Marker in Metastatic Castration-Resistant Prostate Cancer

    Nov 1, 2016, 00:00

  • Evaluating Factors Associated with Depressive Symptoms Among Postpartum Mothers in South Punjab, Pakistan

    Nov 1, 2016, 00:00

  • Structured Review of Health Economic Models in Asthma

    Nov 1, 2016, 00:00

  • Development of Reimbursement of New Examination and Treatment Methods (NUB) in the German DRG-System – Analysis of NUB Applications and NUB Status Since Implementation

    Nov 1, 2016, 00:00

  • Rationale And Design Of A Multi-Center Survey To Evaluate Productivity Losses And Indirect Costs After Cardiovascular Events In Europe

    Nov 1, 2016, 00:00

  • Pharmacological Interventions for Familial Hypercholesterolaemia in Children and Adolescents- A Systematic Literature Review

    Nov 1, 2016, 00:00

  • Cost Effectiveness Analysis of Nilotinib Versus Imatinib in Newly Diagnosed Chronic Myeloid Leukemia from the Health Insurance Perspective in Egypt

    Nov 1, 2016, 00:00

  • Quality of Life in Patients with Diabetes Mellitus II in Czech Republic

    Nov 1, 2016, 00:00

  • The Health And Economic Burden of Obesity In Chile – An Epidemiological And Economic Simulation Model

    Nov 1, 2016, 00:00

  • Health Insurance Cost of Mental and Behavioural Disorders Due to Psychoactive Substance Use in Hungary- A Cost of Illness Study

    Nov 1, 2016, 00:00

  • Sunitinib Dosing Schedules in The Management of Metastatic Renal Cell Carcinoma- A Meta-Analysis

    Nov 1, 2016, 00:00

  • Cost Analysis of the Molecular Screening and Genetic Diagnosis of Lynch Syndrome in Catalonia (Spain)

    Nov 1, 2016, 00:00

  • The Role of Economic Evidence in Drug Reimbursement- South Korea

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Ticagrelor 60 Mg in High-Risk Post-Mi Patients From A Dutch Societal Perspective

    Nov 1, 2016, 00:00

  • Prevalence of Shisha Smoking among Adult Male Cigarette Smokers of Multan, Pakistan

    Nov 1, 2016, 00:00

  • CT And MRI Units In Cyprus- A Market Analysis

    Nov 1, 2016, 00:00

  • Clinical Effectiveness of Carbapenem Versus Alternative Antibiotics For Urinary Tract Infection Due to Enterobacteriaceae Producing Esbl- A Systmatic Review

    Nov 1, 2016, 00:00

  • Improving Access to new Oncology Drugs in the China Market- Shortentime-To-Market and Improve Affordability

    Nov 1, 2016, 00:00

  • Is The Institute Of Clinical And Economic Review (Icer) Set Up For Success? A Comparison Between Icer And Ex-U.S. Hta Agencies

    Nov 1, 2016, 00:00

  • The Economic Cost Of Blindness in Europe

    Nov 1, 2016, 00:00

  • Utilization of Antimicrobial Agents at the Haematology Ward in a Public Hospital

    Nov 1, 2016, 00:00

  • Health Care Direct Cost Burden of Diabetes in Medicare Beneficiaries With Obesity

    Nov 1, 2016, 00:00

  • The Risk of Falls and Fractures Among Those with Overactive Bladder- A Systematic Review

    Nov 1, 2016, 00:00

  • How Real Is “Free Pricing” In The Uk?

    Nov 1, 2016, 00:00

  • Development of An Economic Model To Assess The Cost-Effectiveness of Nitisinone As A Treatment For Alkaptonuria In The UK

    Nov 1, 2016, 00:00

  • Herpes Zoster-Associated Resources Consumption In Chronic Obstructive Pulmonary Disease Patients

    Nov 1, 2016, 00:00

  • Cost-Analysis of Heart Valve Implantations, Complications and Follow-UP Based on National Health Insurers Claims Data in The Netherlands

    Nov 1, 2016, 00:00

  • A Critical Review of Medication Review Tools for Long-Term Care Facilities and Development of a Novel Tool for Qatar

    Nov 1, 2016, 00:00

  • Mapping of The Gastrointestinal Short Form Questionnaire (GSFQ) into SF-6D and EQ-5D in Spanish Population

    Nov 1, 2016, 00:00

  • Budget Impact Analysis of The Permanent Endovascular Adhesive Closure System in The Treatment of Venous Reflux and Chronic Venous Insufficiency (CVI) in Turkey

    Nov 1, 2016, 00:00

  • Overcoming Hta Hurdles Through Early Collaboration Between Pharmaceutical Companies And Companion Diagnostic Companies

    Nov 1, 2016, 00:00

  • Optimising Adverts And Campaigns For Efficient And Cost-Effective Patient Recruitment Using Social Media

    Nov 1, 2016, 00:00

  • Budget Impact of Apremilast for Moderate to Severe Plaque Psoriasis in the UK

    Nov 1, 2016, 00:00

  • Analysis of the Relationship Between Blood Pressure in Health Checkup and Effectiveness of Antihypertensives

    Nov 1, 2016, 00:00

  • Translation, Adaptation And Validation Of The Diabetes Distress Scale For Indonesian Diabetic Outpatients With Various Types Of Complications

    Nov 1, 2016, 00:00

  • A Decision-Focused Network Meta-Analysis (NMA) of Dipeptidyl Peptidase-4 (DPP4) Inhibitors Used In Combination With Metformin And A Sulfonylurea For The Treatment of Type 2 Diabetes Mellitus (T2DM)

    Nov 1, 2016, 00:00

  • Analysis of Affordability and Consumption of Antihypertensive Fixed Combinations of Drugs in Ukraine

    Nov 1, 2016, 00:00

  • Assessment of A Pilot Program on Cervical Cancer Screening Carried out By Health Visitors In Hungary

    Nov 1, 2016, 00:00

  • Estimating the Utility Associated with Mode of Treatment Administration in Gaucher Disease

    Nov 1, 2016, 00:00

  • Relationship Between Orphan Disease Prevalence, Differential Hta Value Assessment, And Orphan Drug Pricing In Seven European Countries

    Nov 1, 2016, 00:00

  • The Future Of Uk Drug Pricing- The 2014 Pprs (An Interim Review)

    Nov 1, 2016, 00:00

  • Effect of CVD on COPD Related Resource Utilization and Direct Medical Costs Among Statutory Heatlh Insured Patients In Germany

    Nov 1, 2016, 00:00

  • Psychometric Testing Of The Finnish Version Of The Prosthesis Evaluation Questionnaire

    Nov 1, 2016, 00:00

  • On a Design Issue of EQ-5D-3l Valuation Studies- Should Likelihood of the Health States Be Considered?

    Nov 1, 2016, 00:00

  • Internal Consistency and Construct Validity of Patient-Reported Outcomes in Primary Progressive Multiple Sclerosis

    Nov 1, 2016, 00:00

  • The Intergenerational Transmission of Adiposity Across Countries

    Nov 1, 2016, 00:00

  • The Chickenpox Complications and Financial Burden in Healthy Children and with Underlying a Comorbidity During the Pre Vaccine and Post Vaccine Era in a University Hospital

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Secukinumab Compared with Ustekinumab And Etanercept for the Treatment Of Moderate-to-Severe Plaque Psoriasis in Greece

    Nov 1, 2016, 00:00

  • Real World Data- Use of Novel Treatments and Biomarkers in Malignant Melanoma in European Countries

    Nov 1, 2016, 00:00

  • Network Meta-Analysis To Assess The Relative Efficacy And Safety of Linagliptin, Empagliflozin And The Fixed Dose Combination of Empagliflozin And Linagliptin In Patients With Type 2 Diabetes Mellitus (T2DM)

    Nov 1, 2016, 00:00

  • Clinical and Comparative Effectiveness of Telemonitoring Intervention Versus Usual Care For Hypertension- A Systematic Review and Meta-Analysis

    Nov 1, 2016, 00:00

  • Treatment Gap of Ulcerative Colitis In Children And Adolescents In Poland - Cost-Utility Analysis of Biosimilar Infliximab

    Nov 1, 2016, 00:00

  • Is it Really Cost-Effective to Risk-Assess all Hospitalized Patients for Pressure Ulcers Every Nursing-Shift?

    Nov 1, 2016, 00:00

  • Predicted Demand For A New Injectable Solution For Delivering Glaucoma Medicine

    Nov 1, 2016, 00:00

  • Systematic Review of Cost Effectiveness Analysis of Ivabradine in Heart Failure

    Nov 1, 2016, 00:00

  • The Burden Associated with Intra-Operative Anastomotic Leaks in Colorectal Surgery

    Nov 1, 2016, 00:00

  • Patient-Reported Outcomes In Relapsed/Refractory Multiple Myeloma (Rrmm) In The Overall And Japanese Populations From Eloquent-2

    Nov 1, 2016, 00:00

  • Effectiveness of Antiviral Therapy for Genotype 1 Chronic Hepatitis C in Real-World Patients from the Valencian Community (Spain)

    Nov 1, 2016, 00:00

  • Designing A Discrete Choice Experiment To Measure Patient Preferences And Willingness-To-Pay For Targeted Therapies For Colorectal Cancer In Singapore

    Nov 1, 2016, 00:00

  • Value And Cost Conundrum In Advanced Oncology- Integration Of Value Frameworks Into Cost-Effectiveness Analyes

    Nov 1, 2016, 00:00

  • Practice Based outcome Research in Community Pharmacy

    Nov 1, 2016, 00:00

  • Economic Burden of Anti-Methicillin-Resistant Staphylococcus Aureus (Mrsa) Therapy in Public Hospitals of Paris (Ap-Hp) and Adequacy with the Defined Daily Doses

    Nov 1, 2016, 00:00

  • Assessment of Clinical Value in Oncology- Comparative Analysis of Value Frameworks and HTAS

    Nov 1, 2016, 00:00

  • Validation of A Novel Tool To Predict Outcomes in Patients with Nosocomial Pneumonia

    Nov 1, 2016, 00:00

  • Sensitivity Analysis of Antibiotic Cost in Chronic Suppurative Otitis Media Patients In South India- A Retrospective Observational Study

    Nov 1, 2016, 00:00

  • Psychometric Validation of Anti-Clot Treatment Scale in Japanese Patients with Atrial Fibrillation

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Of Grazoprevir / Elbasvir In Patients With Chronic Hepatitis C Virus

    Nov 1, 2016, 00:00

  • Gender-Specific Patterns of Productivity Loss in Colorectal Cancer Survivors in a Multi-Ethnic Asian Population

    Nov 1, 2016, 00:00

  • Are Drug Procurement Procedure and Award Criteria in EU Hospital Setting Standardized and do they Take into Accounts Effective Supply Quality?

    Nov 1, 2016, 00:00

  • Etiology and Outcome of Acute Kidney Injury in South Indian Population

    Nov 1, 2016, 00:00

  • Budget Impact Analysis of Standard Care with Serelaxin in Treatment of Patients with Acute Decompensated Heart Failure

    Nov 1, 2016, 00:00

  • Incidence of Febuxostat and Allopurinol-Induced Cutaneous Adverse Reaction- A Hospital Based Cohort Study

    Nov 1, 2016, 00:00

  • Valuation of EQ-5D-5L Health States- A Comparison of Three Asian Countries

    Nov 1, 2016, 00:00

  • Assessing The Economic Burden of Heart Failure in Korea- Incremental Cost Approach

    Nov 1, 2016, 00:00

  • Applying The Accepted Techniques of Indirect Treatment Comparison to Meet Payer Needs For Brivaracetam Versus Adjunctive Antiepileptic Medications for The Treatment of Focal Seizures In Adult Patients. Do they reflect the need for individua ...

    Nov 1, 2016, 00:00

  • Multiple Sclerosis- Real-World Healthcare Costs In A Large US Health Plan

    Nov 1, 2016, 00:00

  • Health State Utility Values (Hsuvs) Measured Using The Euroqol 5-Dimensions (Eq-5d) Questionnaire In Adults With Chronic Hepatitis C (Chc)- A Systematic Literature Review (Slr)

    Nov 1, 2016, 00:00

  • Measuring Caregiver Quality of Life; Which Aspects Really Matter?

    Nov 1, 2016, 00:00

  • Influence of Cochrane Evidence on Medical Policies of Oncology Drugs in the United States

    Nov 1, 2016, 00:00

  • Applying for Apheresis Treatment in Germany – Regional Differences Over 5 Years (2010-2014)

    Nov 1, 2016, 00:00

  • Progression and Outcomes of Non-Dialysis Dependent Chronic Kidney Disease Patients

    Nov 1, 2016, 00:00

  • Real-World Evidence on Healthcare Resource use and Associated Cost With Multiple Myeloma in The Netherlands

    Nov 1, 2016, 00:00

  • Marketing Situation and Medical Reform Policy Analysis of Oral Hypoglycemic Drugs in China

    Nov 1, 2016, 00:00

  • Evaluating the Quality of Evidence From the Aspire and Endeavor Clinical Trials Using the Grading of Recommendations, Assessment, Development and Evaluation (Grade) Approach

    Nov 1, 2016, 00:00

  • The Clinical Value of Olmesartan for the Treatment of Hypertensive Patients- A Systematic Review

    Nov 1, 2016, 00:00

  • The Morphological Study of Human Brown Adipose Tissue During Fetal Development

    Nov 1, 2016, 00:00

  • Historical Trends and Correlations of Pulmonary Embolism in Taiwan

    Nov 1, 2016, 00:00

  • Effectiveness of Identifying A Cancer Patient In The Hospital Sector In Northern-Norway - Analyses Based on Regional Performance Database

    Nov 1, 2016, 00:00

  • The Cost-Effectiveness of Blue-Light Therapy Vs Fixed Combination of Calcipotriol and Betamethasone Dipropionate Gel in the Treatment of Mild-To-Moderate Psoriasis

    Nov 1, 2016, 00:00

  • Disease Severity and Control in Adults with a History of Moderate to Severe Atopic Dermatitis- Results from a Large Patient-Physician Survey in the United Kingdom, Germany, and France

    Nov 1, 2016, 00:00

  • Real-Life Persistence of Budesonide/Formoterol Spiromax for The Management of Asthma and COPD in The UK

    Nov 1, 2016, 00:00

  • Budget Impact of Bronchial Thermoplasty In Patients with Uncontrolled Severe Asthma

    Nov 1, 2016, 00:00

  • Prevalence of Low Birthweight and its Correlates from 2008 to 2014 in Xindu County of Chengdu, China

    Nov 1, 2016, 00:00

  • Is Early Initiation of Biologic Treatment more Effective than a Step up Treatment Approach for New Onset Juvenile Idiopathic Arthritis?-- using a Causal Inference Approach to Achieve a Double Robust Estimate

    Nov 1, 2016, 00:00

  • Nice Collateral Effect- What Is The Influence Of Nice On Other Hta Bodies?

    Nov 1, 2016, 00:00

  • To Diagnosis Embryonic Developmental Anomalies of Genetic Origin with Exome Sequencing- A Discrete Choice Experiment to Assess Parents’ Preferences for Disclosure of Findings and Support

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Of Daclizumab Versus Fingolimod In The Treatment Of Patients With Relapsing-Remitting Multiple Sclerosis In Norway

    Nov 1, 2016, 00:00

  • Follow-Up Analysis Of Validity Of Bia For Drugs Temporarily Reimbursed In Mode Of Coverage With Evidence Development

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Analysis Of 52 Mg Levonorgestrel-Releasing Intrauterine System (Lng-Ius) Versus Short-Acting Hormonal Contraceptives In Avoiding Unintended Pregnancy (Up) In 15 To 19 Year-Old Adolescents Under The Brazilian Public Health ...

    Nov 1, 2016, 00:00

  • Expected Impact of the European Society for Medical Oncology Magnitude of Clinical Benefit Scale (Esmo-Mcsb) on Health Technology Assessment

    Nov 1, 2016, 00:00

  • Timeline of Authorization and Reimbursement for Oncological Drugs in Italy- An Integrated Analysis, Across Legislation’s Leverage

    Nov 1, 2016, 00:00

  • The Evpi of Treatment Strategies for Radioiodine-Refractory Differentiated Thyroid Cancer

    Nov 1, 2016, 00:00

  • Prevalence of Potentially Inappropriate Prescribing in Central Nervous System and Psychotropic Drugs for the Korean Elderly- A Cross-Sectional Study Using the National Health Insurance Claims Database

    Nov 1, 2016, 00:00

  • Building Intentions with the Theory of Planned Behaviour- The Mediating Role of Knowledge and Expectations in Implementing New Pharmaceutical Services in Malaysia

    Nov 1, 2016, 00:00

  • The Effect of Depression on Adherence To Hormone Therapy in Breast Cancer Patients

    Nov 1, 2016, 00:00

  • Evaluation of Sulphonylurea Induced Cardiovascular Events in Diabetic Patients in Comparison with Non Sulphonylurea at South Indian Teaching Hospital

    Nov 1, 2016, 00:00

  • Burden of Illness for Patients with Hereditary Attr Amyloidosis with Polyneuropathy Begins with Symptom Onset and Increases with Disease Progression

    Nov 1, 2016, 00:00

  • Hypertension Is Associated With Worse Outcomes Among Hospitalized Children With Autosomal Dominant Polycystic Kidney Disease In The US

    Nov 1, 2016, 00:00

  • Off-Label Use of Ruxolitinib In Refractory Graft-Versus-Host Disease After Allogenic Stem Cell Transplantation

    Nov 1, 2016, 00:00

  • Economic Consequences of The Determinalistic Relation Between Laboratory Tests Indication And Antibiotic Prescription

    Nov 1, 2016, 00:00

  • Health Resource Utilization (HRU) and Costs for Metastatic Renal Cell Carcinoma (MRCC) Patients Treated With First-Line (1l) Systemic Therapy in The United States

    Nov 1, 2016, 00:00

  • Assessing The Consequences Of Sustained Off-Therapy Hbsag Loss In Health Economic Models Of Chronic Hepatitis B; A Systematic Literature Review

    Nov 1, 2016, 00:00

  • Incidence of Germline Brca 1 and 2 Mutated Breast Cancer in The EU5

    Nov 1, 2016, 00:00

  • Managing Effective Access To Biosimilars- In Search Of An Optimal Framework For Catalonia

    Nov 1, 2016, 00:00

  • Acupuncture Treatment for Neuropathic Pain in Spinal Cord Injury

    Nov 1, 2016, 00:00

  • Budget Impact Analysis of Triveram for The Treatment of Hypertension in Italy

    Nov 1, 2016, 00:00

  • clinical Outcomes and Cost-Effectiveness of Novel Oral Anticoagulants Incorporating Real-World Elderly Patients with Atrial Fibrillation

    Nov 1, 2016, 00:00

  • Healthcare Costs Among Multiple Myeloma (MM) Patients (PTS) without Stem Cell Transplant (SCT)

    Nov 1, 2016, 00:00

  • Pragmatic Review of Clinical Efficacy, Safety and Health Care Related Quality of Life (HRQOL) For Transtuzumab Monotherapy in Metastatic HER2+ Breast Cancer (MBC)

    Nov 1, 2016, 00:00

  • Economic Burden Associated with Chronic Myeloid Leukemia (CML) Treatments in The United States- A Systematic Literature Review

    Nov 1, 2016, 00:00

  • Taking In Account Research And Development Expenditures To Determine Prices Of Medicines In Fran A Realistic Alternative Choice?

    Nov 1, 2016, 00:00

  • Epidemiology of Patients Receiving Hematopoietic Stem Cell Patients in Belgium

    Nov 1, 2016, 00:00

  • MD1 Medical Devices- Timely Access and Reimbursement - Can National Health Technology Assessment Bodies Be Part of the Solution?

    Nov 1, 2016, 00:00

  • Structure of HTA Networks From The Perspective of Network Economics

    Nov 1, 2016, 00:00

  • Optimizing COPD Treatment In Portugal – Improving Health Outcomes And Reducing Treatment Costs In Patients with A History of Exacerbation with Indacatrol Plus Glycopyrronium

    Nov 1, 2016, 00:00

  • Healthcare Resource Utilisation is Associated with Phase of Chronic Myeloid Leukaemia (CML)- Results of a Clinical Expert Survey in England and Wales

    Nov 1, 2016, 00:00

  • Does Hospital At Home Need A New Funding For Oral Anti-Cancer Drugs ?

    Nov 1, 2016, 00:00

  • Work Productivity/Interference and General Health Status Improvements with Sirukumab, an Anti-Il-6 Cytokine Monoclonal Antibody, in Patients with Active Rheumatoid Arthritis Despite Treatment with Disease-Modifying Anti-Rheumatic Drugs- Res ...

    Nov 1, 2016, 00:00

  • Delayed Access To Bariatric Surgery In Brazil- Cost-Effectiveness Analysis

    Nov 1, 2016, 00:00

  • The Cost Of Treating Mucormycosis With Isavuconazole Compared With Liposomal Amphotericin B Followed By Posaconazole In The United Kingdom- Economic Evaluation Of The Phase Iii Vital Study And Fungiscope Matched Case-Control Analysis

    Nov 1, 2016, 00:00

  • Cost-Utility of In-Ambulance Telemedicine for Stroke Patients

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Analysis of Long-Term Versus Short-Term Dual Antiplatelet Therapy in Patients with Drug-Eluting Stents

    Nov 1, 2016, 00:00

  • Impact of Cardiovascular Outcome Trial (CVOT) Data on EU5 Access for New Type 2 Diabetes Drugs

    Nov 1, 2016, 00:00

  • Association Between Disease Prevalence, Drug Price and ASMR for Orphan Drugs in France

    Nov 1, 2016, 00:00

  • Review of Data Cuts used as Basis for Statistical Analyses and Derivation of Additional Benefit Presented within German Benefit Assessments for Oncological Drugs

    Nov 1, 2016, 00:00

  • Determination Of Clinical And Cost-Effectiveness Of Various Methods Of Predicting Preterm Birth In Women With High Risk

    Nov 1, 2016, 00:00

  • Healthcare Cost and Utilization Among U.S. Patients with Relapsed/Refractory Systemic Light Chain Amyloidosis (RRAL)

    Nov 1, 2016, 00:00

  • Development and Evaluation of Patient Information Leaflets for Diabetic Foot Ulcer Patients

    Nov 1, 2016, 00:00

  • Theatre Efficiency and Effectiveness- NHS Trust and Industry Partnership

    Nov 1, 2016, 00:00

  • A Qualitative Study Exploring Perception and Attitudes of Community Pharmacists About Extended Pharmacy Services in Lahore, Pakistan

    Nov 1, 2016, 00:00

  • Real World Experience of Sunitinib in Patients with Metastatic Renal Cell Carcinoma; Results from Compassionate use Program in Malaysia

    Nov 1, 2016, 00:00

  • Hemoglobin A1C (A1C) Reduction And Diabetes-Related Health Care Costs Among Type 2 Diabetes (T2DM) Patients Treated With Liraglutide or Exenatide- A Retrospective Claims Database Analysis

    Nov 1, 2016, 00:00

  • Elements of Orphan Drugs Value

    Nov 1, 2016, 00:00

  • Domestic Manufacturing In Russia- Measuring The Success Of The Pharma 2020 Program

    Nov 1, 2016, 00:00

  • Network Meta-Analysis of Antidiabetic Treatments Added To Insulin Therapy In Patients With Type 2 Diabetes Mellitus

    Nov 1, 2016, 00:00

  • Predicting Length Of Stay After Road Traffic Accident Accounting For Competing Endpoints With Time-Dependent Variables

    Nov 1, 2016, 00:00

  • Burden of Congenital Hyperinsulinism In The United Kingdom- A Cost of Illness Study

    Nov 1, 2016, 00:00

  • Quantification Of Patient Preference Analysis- Wearing The Federal Joint Committee Lens To Assess Evidence

    Nov 1, 2016, 00:00

  • Cadth’s $50,000 Cost-Effectiveness Threshold- Fact or Fiction?

    Nov 1, 2016, 00:00

  • Evaluation of The Economic Impact of Ferric Carboxymaltose Use For The French National Health Insurance And The French Hospitals Organization

    Nov 1, 2016, 00:00

  • An Australian National Cost of Illness Study For Hereditary Haemochromatosis

    Nov 1, 2016, 00:00

  • Pharmacoeconomic Evaluation of Cancer Treatments in India

    Nov 1, 2016, 00:00

  • Generalising Results from Cost-Effectiveness Analysis- A Comparison of Methods to Account for Covariates

    Nov 1, 2016, 00:00

  • Reviewing the Economic Impact of Extending the National Immunization Program in Egypt

    Nov 1, 2016, 00:00

  • What is The Level of Transparency in Health Technology Assessment Process in Hungary, Romania and Turkey?

    Nov 1, 2016, 00:00

  • Descriptive Analysis of the Resected Pancreatic Cancer Patient Journey- Findings from a U.S. Real-World Claims-Based Analysis

    Nov 1, 2016, 00:00

  • Economic Evaluation of Cervical Cancer Screening Strategies in China

    Nov 1, 2016, 00:00

  • Economic Evaluation for the United Kingdom of Systemic Chemotherapies as First-Line Treatment for Metastatic Pancreatic Cancer

    Nov 1, 2016, 00:00

  • Insulin Degludec in Clinical Practi A Systematic Review of Japanese Real-World Data

    Nov 1, 2016, 00:00

  • Correlation Between Tea Consumption and Prevalence of Hypertension Among Singaporean Chinese Residents Over 40

    Nov 1, 2016, 00:00

  • Macro-Economic Considerations in Healthcare Decision Making

    Nov 1, 2016, 00:00

  • The Association of Adherence to Disease-Modifying Drugs and Out-of-Pocket Costs in Patients with Multiple Sclerosis

    Nov 1, 2016, 00:00

  • Primary Non-Adherence, Early Non-Persistence, Treatment Reinitiation and Long-Term Adherence Among A Population-Based Cohort of Naïve Patients Prescribed Antiosteoporotics

    Nov 1, 2016, 00:00

  • Impact of Surgical Technique on Length Of Stay and Early Outcomes in Breast Reconstruction- A Preliminary Analysis

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Analysis of Sucroferric Oxyhydroxide in Treatment of Hyperphosphatemia in Patients with Chronic Kidney Disease

    Nov 1, 2016, 00:00

  • Implication Of External Price Referencing On Pharmaceutical List Prices In Europe

    Nov 1, 2016, 00:00

  • Efficacy of Palbociclib Combinations Versus Endocrine Therapies in Advanced/ Metastatic Breast Cancer- Network Meta-Analysis

    Nov 1, 2016, 00:00

  • Cost And Cost Per Responder In Spain of Adalimumab, Methotrexate And Apremilast In The Treatment of Methotrexate-Naïve Patients With Psoriatic Arthritis

    Nov 1, 2016, 00:00

  • The Impact of Pharmacist Intervention on Medication Errors In A Teaching Hospital Quetta, Pakistan

    Nov 1, 2016, 00:00

  • Have Budget Impact Analyses Included Clinical Outcomes?

    Nov 1, 2016, 00:00

  • Patient Characteristics And Outcomes Of Hospitalization For Influenza Infection In Hong Kong

    Nov 1, 2016, 00:00

  • Resource use and Associated Costs for Metastatic Squamous Non-Small Cell Lung Cancer (SQ NSCLC) Patients- A Retrospective Chart Review in Select European Countries

    Nov 1, 2016, 00:00

  • Resource Use In Idiopathic Pulmonary Fibrosis- Influence of Disease Progression and Exacerbations

    Nov 1, 2016, 00:00

  • Prospective Study of the Incidence, Nature and Causes of Dispensing Errors in Community Pharmacies of Ulaanbaatar, Mongolia

    Nov 1, 2016, 00:00

  • Market Access Routes for Orphan Oncology Drugs- How do Health Systems Help Patients Receive Treatments that are not Cost-Effective?

    Nov 1, 2016, 00:00

  • How Assessment Methods May Affect The Efficiency Of Appraisal Process- A Critical Review

    Nov 1, 2016, 00:00

  • Assessing The Cost-Utility of Etelcalcetide- A Markov Model

    Nov 1, 2016, 00:00

  • How Beneficial Is Hrqol Assessment In The Course Of Treatment Decisions In Physical Rehabilitation? Results Of Clinicians' Perspective

    Nov 1, 2016, 00:00

  • Systematic Review of Budget Impact Analysis on Vaccines

    Nov 1, 2016, 00:00

  • Market Potential Of A New Infliximab Biosimilar In The European Market- A Budget Impact Analysis In France, Italy And The Uk

    Nov 1, 2016, 00:00

  • Requirements for Economic Evidence Across Different HTA Bodies

    Nov 1, 2016, 00:00

  • Are treatment sequences, adverse events, long-term disease progression adequately considered in cost-effectiveness analyses of rheumatoid arthritis ?- A critical economic litterature review

    Nov 1, 2016, 00:00

  • Using Social Finance to Fund Generic Drug Repurposing for Rare Diseases- A Social Impact Bond Proof of Concept

    Nov 1, 2016, 00:00

  • Economic And Humanistic Burden of Chronic Spontaneous Urticaria In Brazil- Impact on Work Productivity, Resource Utilization And Quality of Life

    Nov 1, 2016, 00:00

  • Association Between Subjective Well-Being and Health Status Among the Elderly in China- The Influences of Social Support and Social Adjustment

    Nov 1, 2016, 00:00

  • Helping Decision-Makers Visualize Inequities In Health Impact Assessment- Linked Electronic Records, Mortality And Regional Disparities In Portugal

    Nov 1, 2016, 00:00

  • Assessment Of Core Drug Use Indicators Using Who/Inrud Methodology At Primary Health Care Centers In Bahawalpur, Pakistan

    Nov 1, 2016, 00:00

  • Automation Of Hospital Medication Distribution Systems In The Us

    Nov 1, 2016, 00:00

  • Drug Utilization Evaluation Study of Sildenafil in a Tertiary Care Teaching Hospital in India – A Retrospective Analysis

    Nov 1, 2016, 00:00

  • Hcv Treatment with Daas in the ‘Real-World’- How Well Do ‘Real’ Patients Respond? The Irish Perspective

    Nov 1, 2016, 00:00

  • Adherence to Oral Antidiabetic Medication in Type 2 Diabetes Mellitus Clients in the Volta Region of Ghana

    Nov 1, 2016, 00:00

  • Attitudes Adherence and Barriers Among Puplicly Employed GPS Towards Evidence Based Medicine and Clinical Practice Guidelines in Cyprus

    Nov 1, 2016, 00:00

  • Comparison of Caregiver-Rated 3-Level Euroqol-5d (Eq-5d-3l) and Health Utilities Index Mark 3 (Hui3) in Patients with Dementia in Singapore

    Nov 1, 2016, 00:00

  • The Guardians' Choices And Preferences For Imported Surrogate Vaccines In China- Based On A Survey In Shenyang, Liaoning Province

    Nov 1, 2016, 00:00

  • Clinico-Economic Evaluation of Combined Treatment of Diabetic Macular Edema

    Nov 1, 2016, 00:00

  • Predictive Validity of National Nosocomial Infection Surveillance (NNIS) and Study on the Efficacy of Nosocomial Infections (SENIC) Risk Indexes for the Incidence of Surgical Site Infections (SSI) in General Surgery at Hospital Universiti S ...

    Nov 1, 2016, 00:00

  • Assessing Health-Utility Values for Chronic Spontaneous/Idiopathic Urticaria In Real-World Using The EQ-5D- Results From Assure-Csu Study

    Nov 1, 2016, 00:00

  • Advanced Therapies- Widening The Gap Between Payers And Regulators

    Nov 1, 2016, 00:00

  • Pharmacoeconomic Evaluation of Patients Undergoing Hemodialysis At a Tertiary Care Centre

    Nov 1, 2016, 00:00

  • The Economic Burden of Myocardial Infarction in Latin America

    Nov 1, 2016, 00:00

  • Value of Individually Prepared Drugs for Health System

    Nov 1, 2016, 00:00

  • Antineoplastic Drug Expenditure in Panama 2012-2014

    Nov 1, 2016, 00:00

  • Healthcare Resource Utilisation And Cost Of Parkinson’s Disease In The United Kingdom

    Nov 1, 2016, 00:00

  • Real World Evidence In Decision-Making Processes On Public Funding Of Drugs In Poland

    Nov 1, 2016, 00:00

  • Analysis of Pharmacy Claims for High Cost Oncology Products- Abiraterone and Enzalutamide Usage in Mcrpc in Ireland

    Nov 1, 2016, 00:00

  • Defining Real-World Product Performance Using Survival Analysis and Superivsed Machine Learning

    Nov 1, 2016, 00:00

  • From The Unified Parkinson’s Disease Rating Scale (UPDRS) To The EQ-5D Utility Index- Development of A New Mapping Algorithm In Parkinson’s Disease (PD)

    Nov 1, 2016, 00:00

  • The Cost-Effectiveness of Sacubitril/Valsartan for The Treatment of Chronic Heart Failure with Reduced Ejection Fraction in England and Scotland- Applying Real-World Evidence to Enhance Generalisability to A UK Population

    Nov 1, 2016, 00:00

  • Reconsidering EQ-5D; Quality of Life Domains that are Important for Multiple Sclerosis Patients

    Nov 1, 2016, 00:00

  • A Review Of The Quality And Accuracy Of Budget Impact Models For High Cost Drugs In Ireland

    Nov 1, 2016, 00:00

  • The Quality-Adjusted Time Without Symptoms and Toxicity (Q-TWIST) in (IMMUNO)-Oncology- A Systematic Review of the Literature

    Nov 1, 2016, 00:00

  • Productivity Loss of Cancer Patients in Japan

    Nov 1, 2016, 00:00

  • Supplementing the Right Way- Effective Cost Management of Multivitamin Syrups in a Paediatric Hospital

    Nov 1, 2016, 00:00

  • Comparison of Equity Weights of Various Adverse Consequences of Tobacco Use- A Best-Worst Scaling for Two Types of Chinese General Public

    Nov 1, 2016, 00:00

  • Resource Utilization and Costs Associated with the Investigation of Pulmonary Nodules in Quebec, Canada

    Nov 1, 2016, 00:00

  • The Impact of Underusing Lipid-Lowering Medications on the Risk of Heart Attack and Hospitalizations in United States Elderly Population

    Nov 1, 2016, 00:00

  • Cyproterone/Ethinylestradiol and Concomitant Use of other Hormonal Contraceptives in the Netherlands

    Nov 1, 2016, 00:00

  • An Assessment of The Number of Chronic Lymphocytic Leukemia (CLL) Patients Eligible For Front-Line Treatment But Unsuitable For Full-Dose Fludarabine Across The European Union

    Nov 1, 2016, 00:00

  • Predictors of Response to Interferone/Ribavarin Combination Therapy in Chronic Hepatitis C Virus Infection at Upper Egypt

    Nov 1, 2016, 00:00

  • The impact of Local Skin Reactions (LSRS) on Resource Use and Quality of Life Associated with Different Field Therapies for Actinic Keratosis. Results from a Belgian Expert Survey

    Nov 1, 2016, 00:00

  • Drug Utilization in an Outpatient Private Paediatric Setting- An Observational Study

    Nov 1, 2016, 00:00

  • Cost Comparison of Wet Age-Related Macular Degeneration Treatment with Aflibercept or Ranibizumab

    Nov 1, 2016, 00:00

  • Indirect Comparison of Triamcinolone Acetonide with Ranibizumab and Aflibercept for the Treatment of Diabetic Macular Edema

    Nov 1, 2016, 00:00

  • Valuing Health- Results from the Health Auction Valuation Experiment (HAVE) Study

    Nov 1, 2016, 00:00

  • A Budget Impact Analysis of The Introduction of Generic Bosentan For The Treatment of Pulmonary Arterial Hypertension In Greece

    Nov 1, 2016, 00:00

  • Patients’ Preferences Toward Characteristics of Treatment with Biological Agents Differ According to Experience with their Rheumatic Disease and Treatment Received or Prescribed- Results from the Cara Study

    Nov 1, 2016, 00:00

  • 1) Value of The Clinical Decision Support System For Adverse Drug Event Prevention- A Cost-Effectiveness Analysis And Cost-Benefit Analysis

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Analysis of Sulodexide in Patients with Non-Proliferative Diabetic Retinopathy in the Czech Republic

    Nov 1, 2016, 00:00

  • A Systematic Review of The SF-36® Health Survey for Measuring Health-Related Quality of Life In Patients with Ulcerative Colitis

    Nov 1, 2016, 00:00

  • Comparison of Markov Models Used for the Economic Evaluation of Colorectal Cancer Screening- A Systematic Review

    Nov 1, 2016, 00:00

  • Parametric Simulation of Headache Day Frequency Using A Negative Binomial Distribution- A Case Study of Erenumab in Episodic Migraine

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Edoxaban Compared to Warfarin for The Treatment and Secondary Prevention of Venous Thromboembolism in The UK

    Nov 1, 2016, 00:00

  • Comparison of Methods to Assess the Relative Importance of Criteria in Multi-Criteria Decision Analysis- An Evaluation of Orphan Drugs in Russia

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Internet-Delivered Cognitive Behavior Therapy for Adolescent Obsessive-Compulsive Disorder

    Nov 1, 2016, 00:00

  • Health Resources Use In Patients With Human Immunodeficiency Virus (Hiv) Infection. Real world evidence from italian administrative databases

    Nov 1, 2016, 00:00

  • Adapting to the Challenge- How are Innovative Study Designs Being used in Rare Diseases?

    Nov 1, 2016, 00:00

  • What's New in the Guidelines for Submission of Dossier for Listing into the Ministry of Health Medicines Formulary (Mohmf) ?

    Nov 1, 2016, 00:00

  • Estimation of The Budget Saving Potential Due To The Introduction of Benepali®, An Etanercept Biosimilar, For The Treatment of All Licensed Adult Etanercept Indications In Spain

    Nov 1, 2016, 00:00

  • Differences in Long-Term Patient Outcomes with Disease-Modifying Versus Symptomatic Treatments for Alzheimer’s Disease (Ad)

    Nov 1, 2016, 00:00

  • An Observational Study On Helath Related Quality Of Life In Diabetes Mellitus Patients

    Nov 1, 2016, 00:00

  • Clinical And Economic Outcomes Of Pharmacist Intervention During Therapeutic Drug Monitoring Program In Saudi Arabia

    Nov 1, 2016, 00:00

  • Developing A Small Cell Lung Cancer Conceptual Model to Inform Treatment Outcome and Assessment Strategy Decisions in Clinical Research

    Nov 1, 2016, 00:00

  • The Health Economic Impact of Managing CMPA According To Guidelines- Challenging Current Treatment Practise In The UK

    Nov 1, 2016, 00:00

  • Linguistic Validation Of The Finnish Version Of The Visual Analogue Scale Foot And Ankle Instrument

    Nov 1, 2016, 00:00

  • Capacity for Endoscopic Screening for Gastric Cancer in Japan

    Nov 1, 2016, 00:00

  • Pharmacoeconomic Analysis of Treatment of Adult Patients with Severe Uncontrolled Asthma with Omalizumab In Russia

    Nov 1, 2016, 00:00

  • The Impact of Psoriasis Vulgaris on Health Related Quality of Life In Greece

    Nov 1, 2016, 00:00

  • How To Define Relevant Comparators In France? An Analysis Of The Economic Evaluations Submitted By Manufacturers And Reviewed By The Economic Committee (Ceesp) Of The French National Health Authority

    Nov 1, 2016, 00:00

  • Health State Utilities Associated with Post-Surgical Staphylococcus Aureus Infection

    Nov 1, 2016, 00:00

  • Heterogeneous Preferences For Delaying Onset Of Alzheimer’s Disease Among Older Adults In The Us

    Nov 1, 2016, 00:00

  • Direct Cost Estimation of Psoriasis Treatment in Turkey- Results from a Delphi Panel

    Nov 1, 2016, 00:00

  • Long Term Outcome of Couples Undertaking their First IVF/ICSI Attempt- A French Study

    Nov 1, 2016, 00:00

  • Estimation Of Value Of Life With A Model Approach Depending On Net Present Value For Turkey

    Nov 1, 2016, 00:00

  • The Use Of Pharmacoeconomic Evidence To Encourage Generic Medicines Use In Jordan- A Cost Minimization Analysis

    Nov 1, 2016, 00:00

  • A Review of the Use of Network Meta-Analysis In Nice Single Technology Appraisals

    Nov 1, 2016, 00:00

  • Risk of Discontinuation of Advanced Therapy Medicinal Products Clinical Trials

    Nov 1, 2016, 00:00

  • Quality of Life in Patients with Total Knee Replacement in Czech Republic

    Nov 1, 2016, 00:00

  • Budget Impact Analysis Of The Introduction Of Darunavir 800 Mg Qd For The 2nd Line Treatment Of Hiv-Infected Treatment-Experienced Adults On The Brazilian National Hiv Program

    Nov 1, 2016, 00:00

  • Behavior of Vas Measures of Patient Satisfaction with Remote Monitoring of Cardiac Implantable electronic devices. The valiosa questionnaire

    Nov 1, 2016, 00:00

  • Comparison Between the EQ-5D-5l and the EQ-5D-3l for General Population in China

    Nov 1, 2016, 00:00

  • The Risks of Using Chinese Medications Associated with Cardiovascular Disease, Diabetes Mellitus, and Chronic Kidney Disease- A Systematic Review

    Nov 1, 2016, 00:00

  • Workload Analysis And Staffing Requirement Of Clinical Pharmacy Services At Ministry Of Health In Saudi Arabia

    Nov 1, 2016, 00:00

  • Risk Sharing Agreements (RSA)- Exploratory Analysis of the Current Situation in Developed and Emerging Markets

    Nov 1, 2016, 00:00

  • Market Access Agreements- What Impacts Drugs Purchasing in French Hospitals

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Dabigatran vs. Rivaroxaban and Vitamin K Antagonists in Elderly Patients with Nonvalvular Atrial Fibrillation in Spain

    Nov 1, 2016, 00:00

  • International Reference Pricing's Evolution In China

    Nov 1, 2016, 00:00

  • Assessment of Channelling Bias Among Initiators of Glucose Lowering Drugs - A Cohort Study

    Nov 1, 2016, 00:00

  • Treatment of Hypertension in Elderly - Pharmacoeconomic Evaluation

    Nov 1, 2016, 00:00

  • Impact Of The Introduction Of New Branded Generic Equivalents On The Prescribing Patterns Of Anti-Dementia Medication

    Nov 1, 2016, 00:00

  • Comparative Efficacy and Saftey of Interventions in The Treatment of Advanced Soft Tissue Sarcoma- A Systematic Review and Network Meta Analysis

    Nov 1, 2016, 00:00

  • Delays In Breast Cancer Diagnosis And Initiation of Treatment- Implementing The Pathways To Treatment Model In The Greek Setting

    Nov 1, 2016, 00:00

  • Role of Genetic Variation in Type Repeats of Histidine Rich Protein-2 Gene in Altering the Performance of Malaria Rapid Detection Kit in Global Context

    Nov 1, 2016, 00:00

  • A Qualitative Study Evaluating The Attitude and Perception of Physician and Pharmacist Towards Pharmacovigilance in Abbottabad, Pakistan

    Nov 1, 2016, 00:00

  • Societal And-Economic Burden of Iron Deficiency Among Swiss Women – Results from a Household Survey

    Nov 1, 2016, 00:00
  • «
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77 (current)
  • 78
  • 79
  • 80
  • »